表 1.
胃癌组织中RAB7A表达量与临床病理参数间的关系
Relationship between RAB7A expression in gastric cancer tissues and clinicopathological parameters of the patients
| Clinicopathological parameters | n | RAB7A | χ2 | P | |
| Low expression (n=52) | High expression (n=52) | ||||
| Gender | 0.502 | 0.478 | |||
| Female | 23 | 13(56.52%) | 10(43.48%) | ||
| Male | 81 | 39(48.15%) | 42(51.85%) | ||
| Age (year) | 0.399 | 0.527 | |||
| ＜60 | 33 | 18(54.55%) | 15(45.45%) | ||
| ≥60 | 71 | 34(47.89%) | 37(52.11%) | ||
| Tumor size (cm) | 0.962 | 0.327 | |||
| ＜5 | 51 | 23(45.10%) | 28(54.90%) | ||
| ≥5 | 53 | 29(54.72%) | 24(45.28%) | ||
| Histological grading | 1.943 | 0.163 | |||
| G1-G2 | 61 | 27(44.26%) | 34(55.74%) | ||
| G3-G4 | 43 | 25(58.14%) | 18(41.86%) | ||
| T Stage | 9.979 | 0.002 | |||
| T1-T2 | 58 | 37(63.79%) | 21(36.21%) | ||
| T3-T4 | 46 | 15(32.61%) | 31(67.39%) | ||
| N Stage | 5.547 | 0.019 | |||
| N0-N1 | 50 | 31(62.00%) | 19(38.00%) | ||
| N2-N3 | 54 | 21(38.89%) | 33(61.11%) | ||
| CEA (μg/L) | 5.613 | 0.018 | |||
| ＜5 | 46 | 29(63.04%) | 17(36.96%) | ||
| ≥5 | 58 | 23(39.66%) | 35(60.34%) | ||
| CA19-9 (kU/L) | 7.385 | 0.007 | |||
| ＜37 | 78 | 45(57.69%) | 33(42.31%) | ||
| ≥37 | 26 | 7(26.92%) | 19(73.08%) | ||